Disappearance Rates of Coagulation Factors: Transfusion Studies in Factor‐Deficient Patients
暂无分享,去创建一个
[1] P. Owren,et al. Surgery in a patient with factor V (proaccelerin) deficiency. , 2009, Acta medica Scandinavica.
[2] M. Blombäck,et al. On an inherited autosomal hemorrhagic diathesis with antihemophilic globulin (AHG) deficiency and prolonged bleeding time. , 2009, Acta medica Scandinavica.
[3] H. Horowitz,et al. Survival of Factor XI in Vitro and in Vivo , 1965, Transfusion.
[4] R. Rosenthal,et al. PTA (factor XI) levels and coagulation studies after plasma infusions in PTA-deficient patients. , 1965, The Journal of laboratory and clinical medicine.
[5] F. Kazmier,et al. EFFECT OF ORAL ANTICOAGULANTS ON FACTORS VII, IX, X, AND II. , 1965, Archives of internal medicine.
[6] H. Hemker,et al. The Biological Half-Time of Hageman Factor , 1965, Thrombosis and Haemostasis.
[7] H. Roberts,et al. HEMOSTASIS IN FACTOR V DEFICIENCY , 1964, The American journal of the medical sciences.
[8] V. Marder,et al. CLINICAL ASPECTS OF CONGENITAL FACTOR VII DEFICIENCY. , 1964, The American journal of medicine.
[9] Massouras Hg,et al. RESPIRATION AND THE CEREBROSPINAL FLUID. , 1964 .
[10] Pool Jg,et al. HIGH-POTENCY ANTIHAEMOPHILIC FACTOR CONCENTRATE PREPARED FROM CRYOGLOBULIN PRECIPITATE. , 1964 .
[11] R. Gage,et al. CONGENITAL DEFICIENCY OF FACTOR VII (HYPOCONVERTINEMIA). CRITICAL REVIEW OF LITERATURE AND REPORT OF THREE CASES, WITH EXTENSIVE PEDIGREE STUDY AND EFFECT OF TRANSFUSIONS. , 1964, The American journal of medicine.
[12] O. Prou-Wartelle,et al. Demi-vie de la prothrombine vraie (facteur II) , 1964 .
[13] J. Niemetz,et al. Blood PTA (Factor XI) Levels Following Plasma Infusion.∗ , 1964, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[14] E. Bowie,et al. THE STABILITY OF ANTIHEMOPHILIC GLOBULIN AND LABILE FACTOR IN HUMAN BLOOD. , 1964, Mayo Clinic proceedings.
[15] R. Biggs,et al. The Fate of Prothrombin and Factors VIII, IX and X Transfused to Patients Deficient in these Factors , 1963, British journal of haematology.
[16] E. Adelson,et al. The survival of factor VIII (antihemophilic globulin) and factor IX (plasma thromboplastin component) in normal humans. , 1963, The Journal of clinical investigation.
[17] R. Biggs,et al. The Treatment of Haemorrhage in von Willebrand's Disease and the Blood Level of Factor VIII (AHG) , 1963, British journal of haematology.
[18] J. Caen,et al. Transfusion Studies in von Willebrand's Disease: Effect on Bleeding Time and Factor VIII , 1963, British journal of haematology.
[19] A. Hensen,et al. Substitution Therapy in Haemophilia B , 1961, Thrombosis and Haemostasis.
[20] C. Mcmillan,et al. A study of fibrinogen turnover in classical hemophilia and congenital afibrinogenemia. , 1961, Blood.
[21] V. Donaldson. Bleeding Syndromes: A Clinical Manual , 1961 .
[22] P. M. Aggeler. Physiological Basis for Transfusion Therapy in Hemorrhagic Disorders: A Critical Review , 1961, Transfusion.
[23] J. Graham,et al. Plasma Thromboplastin Component (Christmas Factor, Factor IX) Levels in Stored Human Blood and Plasma , 1960, Thrombosis and Haemostasis.
[24] M. Hoag,et al. Disappearance rate of concentrated proconvertin extracts in congenital and acquired hypoproconvertinemia. , 1960, The Journal of clinical investigation.
[25] C. Owen,et al. Soybean phosphatides in prothrombin-consumption and thromboplastin-generation tests: their use in recognizing "thrombasthenic hemophilia". , 1960, American journal of clinical pathology.
[26] van der Esch,et al. Factor VII: its Turnover Rate and its Possible Role in Thrombogenesis , 1960, Thrombosis and Haemostasis.
[27] C. Borchgrevink,et al. A Study of a Case of Congenital Hypoprothrombinaemia , 1959, British journal of haematology.
[28] J. Soulier,et al. Preparation of a human plasma fraction rich in prothrombin, proconvertin, Stuart factor, and PTC and a study of its activity and toxicity in rabbits and man. , 1959, The Journal of laboratory and clinical medicine.
[29] Douglas As. Antihemophilic globulin assay following plasma infusions in hemophilia. , 1958 .
[30] R. Macmillan,et al. A MODIFICATION OF THE THROMBOPLASTIN GENERATION TEST , 1958, The American journal of the medical sciences.
[31] R. Biggs. Assay of antihaemophilic globulin in treatment of haemophilic patients. , 1957, Lancet.
[32] R. G. Macfarlane,et al. Surgery in haemophilia; the use of animal antihaemophilic globulin and human plasma in thirteen cases. , 1957, Lancet.
[33] J. Case,et al. The stability of Christmas factor; a guide to the management of Christmas disease. , 1956, Lancet.
[34] C. A. Owen,et al. Evaluation of disorders of blood coagulation in the clinical laboratory. , 1955, American journal of clinical pathology.
[35] C. A. Owen,et al. Dextran as a substitute for acacia in assay of plasma prothrombin. , 1955, American journal of clinical pathology.
[36] S. Creveld. Congenital Idiopathic Hypoprothrombinemia 1 , 1954, Acta paediatrica. Supplementum.
[37] D. Gitlin,et al. Studies on the metabolism of fibrinogen in two patients with congenital afibrinogenemia. , 1953, Blood.
[38] A. S. Douglas,et al. The Thromboplastin Generation Test , 1953, Journal of clinical pathology.
[39] A. S. Douglas,et al. The Measurement of Prothrombin in Plasma , 1953, Journal of clinical pathology.
[40] B. Alexander,et al. Parahemophilia in three siblings (Owren's disease). , 1952, The American journal of medicine.
[41] E. Frank,et al. Die Parahämophilie (Owren), eine neue Form der hämorrhagischen Diathese , 1950 .
[42] A. Quick,et al. The prothrombin consumption test; its clinical and theoretic implications. , 1949, Blood.
[43] A. Quick. On the quantitative estimation of prothrombin. , 1945, American journal of clinical pathology.
[44] E. Warner,et al. A QUANTITATIVE STUDY ON BLOOD CLOTTING: PROTHROMBIN FLUCTUATIONS UNDER EXPERIMENTAL CONDITIONS , 1936 .
[45] E. E. Ecker,et al. AN IMPROVED METHOD FOR COUNTING BLOOD PLATELETS , 1923 .
[46] W. Crofton. Section of medicine , 1921 .
[47] W. W. Duke. The Relation of Blood Platelets to Hemorrhagic Disease: Description of a Method for Determining the Bleeding Time and Coagulation Time and Report of Three Cases of Hemorrhagic Disease Relieved by Transfusion , 1910 .
[48] [Fibrin stabilizing factor (FSF)]. , 1968, Il Policlinico. Sezione pratica.
[49] P. Hjort,et al. Turnover of prothrombin, factor VII and factor IX in a patient with hemophilia A. , 1961, Scandinavian journal of clinical and laboratory investigation.
[50] J. Graham. Stuart clotting defect and Stuart factor. , 1960, Thrombosis et diathesis haemorrhagica.
[51] Graham Jb. Stuart clotting defect and Stuart factor. , 1960 .
[52] F. Duckert. On the properties of the Stuart-Prower factor. , 1960, Thrombosis et diathesis haemorrhagica.
[53] A. S. Douglas. Antihemophilic globulin assay following plasma infusions in hemophilia. , 1958, The Journal of laboratory and clinical medicine.
[54] P. Frick. Studies on the turnover rate of stable prothrombin conversion factor in man. , 1958, Acta haematologica.
[55] J. Wilkinson,et al. Changes in the blood-clotting defect in Christmas disease after plasma and serum transfusions. , 1958, Clinical science.
[56] K. Brinkhous,et al. Physiologic basis of transfusion therapy in hemophilia. , 1956, A.M.A. archives of pathology.
[57] N. W. Barker,et al. The determination of prothrombin time following the administration of dicumarol, 3,3'-methylenebis (4-hydroxyconmarin), " with special reference to thromboplastin. , 1945 .